EORTC-NCI-AACR 2010: Essential Role of Fibroblast Growth Factor Receptor 2 (FGFR2) in Tumorigenesis of Human Cancers Harboring FGFR2 Amplification Demonstrated by a Functional Blocking Antibody
TIVO-3: Final OS Analysis Of A Phase III, Randomized, Controlled, Multicenter, Open-Label Study To Compare Tivozanib To Sorafenib In Subjects With Metastatic Renal Cell Carcinoma (RCC)
